Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 38 results found. Search for [ dr reddys lab ]

Results 1 to 21 of 38
E Kumar Sharma
New Delhi, November 2, 2019
Dr Reddy's CFO Saumen Chakraborty attributed much of the challenges in the US market to price erosion and lower volumes


BusinessToday.In
November 1, 2019
According to official data, the Air Quality Index in Delhi and surrounding areas of Noida, Ghaziabad, Gurugram and Faridabad region crossed the 500 mark and entered into Severe Plus / Emergency Category


PTI
November 1, 2019
The unions said ensuring \"proper governance in the system\" and \"removing political interference\" will address the problem of NPAs that has been weakening the financial health of the PSBs


Sonal Khetarpal
November 1, 2019
Even though majority (57 per cent) think content censorship in important, many (36 per cent) believe regulation should only be for mass mediums like TV and films but not for online mediums


PTI
May 17, 2019
Revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same quarter last fiscal, the city-based drug-maker said in a press release.


E Kumar Sharma
October 26, 2018
The pharma major had posted a robust performance in the June quarter of FY19, largely aided by the launch in the US of gSuboxone, the generic version of the drug to deal opioid addiction.


PTI
June 4, 2018



BT Online
New Delhi, November 19, 2015
All sectors except healthcare closed the day in the green with strong gains made by financial and IT stocks that were beaten down in the previous session.


BusinessToday.in
New Delhi, October 21, 2015
The S&P BSE Sensex wiped out all its early gaines and fell 19.17 points to end at 27,287.66 as pharma and banking stocks failed to shape up.


BT Online
New Delhi, September 28, 2015
Sun Pharma Advanced Research Co Ltd (SPARC) closed 2.62 per cent down at Rs 375.80 apiece on Monday after USFDA revoked approval for SPARC's seizure drug, citing manufacturing quality problems at its production site.


IANS
New Delhi, September 14, 2015
The exclusive rights for this product are applicable for the US, Canada, India, Russia and the CIS, Australia, New Zealand and Venezuela.


BT Online Bureau
New Delhi, July 30, 2015
The firm posted operating profit of Rs 771 crore in the reporting quarter against Rs 647 crore in the Q1 of last fiscal.


PTI
New Delhi, June 19, 2015
With regard to acquisition of select portfolio of the established products business of UCB in India, Dr Reddy's Laboratories has concluded the transaction, the company said in a filing to the BSE.


E. Kumar Sharma
January 27, 2015
The 270-page book is an anecdotal account of the way Dr K Anji Reddy, founder of Dr Reddy's Labs, who many regard as a pioneer in Indian pharma industry, saw his company and the industry evolve.


E. Kumar Sharma
December 5, 2014
At work, G.V. Prasad, Co-Chairman and CEO of Dr. Reddy's Labs can take both the wide-angle and the close-up view - different mentors taught him the value of each.


PTI
New Delhi, November 26, 2014
Ranbaxy Laboratories had sued US Food and Drug Administration (USFDA) over revoking an approval to sell generic versions of Nexium and Valcyte in the US market.


Zeba Siddiqui
Mumbai, November 18, 2014
The FDA told Ranbaxy that its decision to grant approvals for both the drugs were \"in error\", after it found that Ranbaxy's plants did not meet its quality standards.


Zeba Siddiqui
Mumbai, November 12, 2014
Leading generic drugmakers Dr Reddy's Labs and Glenmark Pharma in November posted a drop in their second-quarter US sales, blaming the slowdown in the approval process.


E Kumar Sharma
November 7, 2014
The FDA has also denied Ranbaxy 180-day marketing exclusivity for a generic version of Roche's antiviral drug Valcyte, according to a company statement on Thursday.


Zeba Siddiqui
Mumbai, November 7, 2014
The move comes after Ranbaxy Labs said on Thursday that FDA had stripped the company of its tentative approval to launch the first copy of the drug due to quality control issues at its plants.


PAGES 1 OF 2  12